3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Melanoma
14
Squamous Cell Carcinoma of Head and Neck
12
Colorectal Neoplasms
11
Carcinoma, Non-Small-Cell Lung
10
Breast Neoplasms
10
Carcinoma, Renal Cell
7
Prostatic Neoplasms
6
Head and Neck Neoplasms
6
Diabetes Mellitus, Insulin-Dependent, 12
6
Neoplasms
5
Lung Neoplasms
5
Biliary Tract Neoplasms
5
Small Cell Lung Carcinoma
4
Ovarian Neoplasms
4
Uterine Cervical Neoplasms
3
Urinary Bladder Neoplasms
3
Recurrence
3
Pancreatic Neoplasms
3
Neoplasm Metastasis
3
Fallopian Tube Neoplasms
3
Cholangiocarcinoma
3
Carcinoma, Hepatocellular
3
Advanced Solid Tumors
3
Stomach Neoplasms
2
Sarcoma
2
Recurrent Squamous Cell Lung Carcinoma
2
Liver Neoplasms
2
Kidney Neoplasms
2
Gallbladder Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Interventions
Gemcitabine
2
tremelimumab
1
pamrevlumab
1
folfirinox
1
durvalumab
1
Leucovorin
1
Irinotecan
1
Fluorouracil
1
Albumin-Bound Paclitaxel
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Pancreatic Cancer Non-resectable
×
tremelimumab
×
Clear all
NCT04156087
2024-09-19
MIMIPAC
University Hospital, Gasthuisberg
Phase 2
Completed
12 enrolled